Carbonic Anhydrase As Biomarker For Cancer Diagnosis

  IJETT-book-cover  International Journal of Engineering Trends and Technology (IJETT)          
© 2021 by IJETT Journal
Volume-69 Issue-4
Year of Publication : 2021
Authors : Alicia Alva, Daniel Ramos-Sono, Juan Faya Castillo, Michael Cieza-Terrones, Lina Cardenas-Pineda, Alexi Delgado
DOI :  10.14445/22315381/IJETT-V69I4P212


MLA Style: Alicia Alva, Daniel Ramos-Sono, Juan Faya Castillo, Michael Cieza-Terrones, Lina Cardenas-Pineda, Alexi Delgado "Carbonic Anhydrase As Biomarker For Cancer Diagnosis" International Journal of Engineering Trends and Technology 69.4(2021):81-86. 

APA Style:Alicia Alva, Daniel Ramos-Sono, Juan Faya Castillo, Michael Cieza-Terrones, Lina Cardenas-Pineda, Alexi Delgado. Carbonic Anhydrase As Biomarker For Cancer Diagnosis  International Journal of Engineering Trends and Technology, 69(4),81-86.

Carbonic Anhydrase (CA) is an enzyme that is integrated into the cell membrane that stimulates the reversible hydration of CO2 producing bicarbonate and hydrogen ions, and its study has gained relevance in the last years because it is related to several types of cancer such as; lung, kidney, colon, uterus, and stomach cancer (4, 5, 6,7,8). Therefore, different studies report carbonic anhydrase as an excellent biomarker for the early detection of lung cancer. Over the last few years, it is being used as a biomarker for the detection of lung cancer, as mentioned by Lin et al. (48), in their work, where they report a direct relationship between the overexpression of carbonic anhydrase and lung cancer. The present study assesses different methods where techniques are used to evaluate it by means of an electrochemical biosensor. These techniques will enable us to continue with the analysis of the characteristics that allow the recognition of carbon anhydrase in a range of 1.08-1.32mM with an acceptable sensitivity with a response time of 1s, demonstrating a promising technology for the application of lung cancer detection.

[1] Shawn C Chafe & Shoukat Dedhar., Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development, OncoImmunology, 4(12)(2015), DOI: 10.1080/2162402X.2015.1048955
[2] Meldrum U., Roughton FJ. CARBONIC ANHYDRASE. ITS PREPARATION AND PROPERTIES. J Physiol. 80(2)(1933) 113–42.
[3] Banerjee S, Deshpande PA. On origin and evolution of carbonic anhydrase isozymes: A phylogenetic analysis from whole-enzyme to the active site. Comput Biol Chem [Internet]. 2016;61:121–9. Available from:
[4] Mboge MY, Mahon BP, McKenna R, Frost SC. Carbonic anhydrases: Role in pH control and cancer. Metabolites. 8(1)(2018) 5. Rogers DM, Jiao D, Pratt LR, Rempe SB. Structural Models and Molecular Thermodynamics of Hydration of Ions and Small Molecules [Internet]. Annual Reports in Computational Chemistry. Elsevier; 8(2012). 71–127 Available from
[5] Smyth, L. G., O`Hurley, G., O`Grady, A., Fitzpatrick, J. M., Kay, E., & Watson, R. W., Carbonic anhydrase IX expression in prostate cancer. Prostate cancer and prostatic diseases, 13(2)(2010) 178–181.
[6] Winum, J. Y., Scozzafava, A., Montero, J. L., & Supuran, C. T., Inhibition of carbonic anhydrase IX: a new strategy against cancer. Anti-cancer agents in medicinal chemistry, 9(6)(2009) 693–702.
[7] Nakao, M., Ishii, G., Nagai, K., Kawase, A., Kenmotsu, H., Kon-No, H., Hishida, T., Nishimura, M., Yoshida, J., & Ochiai, A., Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma. Cancer, 115(12)(2009) 2732–2743.
[8] Kim, S. J., Rabbani, Z. N., Vollmer, R. T., Schreiber, E. G., Oosterwijk, E., Dewhirst, M. W., Vujaskovic, Z., & Kelley, M. J., Carbonic anhydrase IX in early-stage non-small cell lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 10(23)(2004) 7925–7933.
[9] Vermylen, P., Roufosse, C., Burny, A., Verhest, A., Bosschaerts, T., Pastorekova, S., Ninane, V., & Sculier, J. P., Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. The European respiratory journal, 14(4)(1999) 806–811.
[10] Joss D, Vogel R, Zimmermann K, Häussinger D. Application of Paramagnetic Lanthanoid Chelating Tags in NMR Spectroscopy and Their Use for the Localization of Ligands Within Biomacromolecules. In: Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Elsevier; (2020).
[11] Mckenna R, Frost SC. Chapter 1: Overview of the Carbonic Anhydrase Family. In: Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. (2014).
[12] Waheed A, S. Sly W, A. Doisy E. Carbonic Anhydrase XII Functions in Health and Disease Abdul. Physiol Behav. 176(12)(2017) 139–48.
[13] Monroy LE, Vargas MPS. Anhidrasa carbónica, nuevas perspectivas. Rev del Inst Nac Enfermedades Respir. 69(4)(2010) 200–9.
[14] Supuran C. Carbonic Anhydrases An Overview. Curr Pharm Des. 14(7)(2008) 603–14.
[15] Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 473(14)(2016) 2023–32.
[16] Imtaiyaz Hassan M, Shajee B, Waheed A, Ahmad F, Sly WS. Structure, function, and applications of carbonic anhydrase isozymes. Bioorganic Med Chem [Internet]. 21(6)(2013) 1570–82. Available from:
[17] Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019. Expert Opin Ther Pat [Internet]. 29(10)(2019) 781–92. Available from:
[18] Berrino E, Carta F. Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity [Internet]. Carbonic Anhydrases: Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target. Elsevier Inc.; (2019). 311–329 Available from
[19] Becker HM, Klier M, Deitmer JW. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Subcell Biochem [Internet]. (2014) 75:105–34. Available from:
[20] Moyano Miñoz JJA, Chimoy Effio PJ. Cáncer, principios y estadísticas. 1st ed.
[21] Singh S, Lomelino CL, Mboge MY, Frost SC, McKenna R. Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules. 23(5)(2018).
[22] Arvelo F, Cotte C. Hipoxia en la malignidad del cáncer. Revisión. Invest Clin.50(4)(2009) 529–46.
[23] Mahon BP, Pinard MA, McKenna R. Targeting carbonic anhydrase IX activity and expression. Molecules., 20(2)(2015) 2323–48.
[24] Spencer NY, Stanton RC. The Warburg Effect, Lactate, and Nearly a Century of Trying to Cure Cancer. Semin Nephrol [Internet]. 39(4)(2019) 380–93. Available from:
[25] Lomelino C, McKenna R. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016). Expert Opin Ther Pat.26(8)(2016) 947–56.
[26] Neri D, Supuran CT. Interfering with pH regulation in tumors as a therapeutic strategy. Nat Rev Drug Discov [Internet].10(10)(2011) 767–77. Available from:
[27] Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. (1994).
[28] Bartoov M, Parkkila S, Pohlodek K, Karttunen TJ, Galbav T, Mucha V, et al. Expression of carbonic anhydrase IX in the breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol. 197(3)(2002) 314–21.
[29] Pastorekova S, Gillies RJ. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 38(2019) (1–2) 65–77.
[30] Türeci Ö, Sahin U, Vollmar E, Siemer S, Göttert E, Seitz G, et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A. 95(13)(1998) 7608–13.
[31] Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 158(3)(2001) 905–19?
[32] Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. Dec 15;60(24)(2000) 7075–83.
[33] Sabina Zamanova, Ahmed M Shabana, Utpal K Mondal and MAI. Carbonic anhydrases as disease markers. Physiol Behav. 176(12)(2017) 139–48.
[34] Aspatwar A, Tolvanen MEE, Parkkila S. Phylogeny and expression of carbonic anhydrase-related proteins. BMC Mol Biol. (2010) 11.
[35] Cardoso JCR, Ferreira V, Zhang X, Anjos L, Félix RC, Batista FM, et al. Evolution and diversity of alpha-carbonic anhydrases in the mantle of the Mediterranean mussel (Mytilus galloprovincialis). Sci Rep. 9(1)(2019) 1–14.
[36] Emameh RZ, Barker H, Tolvanen MEE, Ortutay C, Parkkila S. Bioinformatic analysis of beta carbonic anhydrase sequences from protozoans and metazoans. Parasites and Vectors [Internet].;7(1)(2014) 1–12. Available from: Parasites & Vectors
[37] Kopecka J, Campia I, Jacobs A, Frei AP, Ghigo D, Wollscheid B, et al. Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells. Oncotarget.,6(9)(2015) 6776–93.
[38] Zaib S, Saeed A, Stolte K, Flörke U, Shahid M, Iqbal J. New aminobenzenesulfonamide-thiourea conjugates: Synthesis and carbonic anhydrase inhibition and docking studies. Eur J Med Chem [Internet].,78(2014) 140–50. Available. from:
[39] Meenakumari K, Bupesh G, Vasanth S, Vasu CA, Pandian K, Prabhu K, et al. Molecular docking based virtual screening of carbonic anhydrase IX with coumarin (a cinnamon compound) derived ligands. Bio information. 15(10)(2019) 744–9.
[40] Zengin Kurt B, Sonmez F, Durdagi S, Aksoydan B, Ekhteiari Salmas R, Angeli A, et al. Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors. J Enzyme Inhib Med Chem [Internet]. 32(1)(2017) 1042–52. Available from:
[41] Nazarshodeh E, Gharaghani S. Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors. BioSystems [Internet]. (2017) 162:35–43. Available from:
[42] Rahman MM, Karim MR, Ahsan MQ, Khalipha ABR, Chowdhury MR, Saifuzzaman M. Use of computer in drug design and drug discovery: A review. Int J Pharm Life Sci. 1(2)(2012) 1–21.
[43] Romano JD, Tatonetti NP. Informatics and computational methods in natural product drug discovery: A review and perspectives. Front Genet., 10(2019) 1–16.
[44] Ósk Jónsdóttir S, Jørgensen FS, Brunak S. Prediction methods and databases within chemoinformatics: Emphasis on drugs and drug candidates. Bioinformatics. 21(10)(2005) 2145–60.
[45] Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. Drug databases and their contributions to drug repurposing. Genomics [Internet]. 112(2)(2020) 1087–95. Available:
[46] Barua H, Bhagat N, Toraskar (mrs.) M. P. Study of Binding Interactions of Human Carbonic Anhydrase Xii. Int J Curr Pharm Res. 9(1)(2016) 118.
[47] Aditama R, Mujahidin D, Syah YM, Hertadi R. Docking and Molecular Dynamics Simulation of Carbonic Anhydrase II Inhibitors from Phenolic and Flavonoid Group. Procedia Chem. 16(2015) 357–64.
[48] Lin, X. Y., Zhang, H., Tang, N., Zhang, X. P., Zhang, W., Wang, E. H., & Han, Y. C., Expression and diagnostic implications of carbonic anhydrase IX in several tumors with predominantly clear cell morphology. Histopathology, 66(5)(2015) 685–694.
[49] I Putu A. Santosa, Dian Luminto, Anik Widijanti, Catur S. Sutrisnani, Hani Susianti, Diagnostic Value of Hemogram Parameters as a Biomarker in Infection and Sepsis, IJETT International Journal of Medical Science 7(5) (2020) 22-26.
[50] Mudit Singh, Noel Nesakumar, Swaminathan Sethuraman, Uma Maheswari Krishnan, John Bosco Balaguru Rayappan, Electrochemical biosensor with ceria–polyaniline core-shell nano-interface for the detection of carbonic acid in the blood, Journal of Colloid and Interface Science,425(2014)52-58, ISSN 0021-9797,

Carbonic Anhydrase, lung Cancer, diagnostics, biomarker.